Insulet Net Worth

Insulet Net Worth Breakdown

  PODD
The net worth of Insulet is the difference between its total assets and liabilities. Insulet's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Insulet's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Insulet's net worth can be used as a measure of its financial health and stability which can help investors to decide if Insulet is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Insulet stock.

Insulet Net Worth Analysis

Insulet's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Insulet's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Insulet's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Insulet's net worth analysis. One common approach is to calculate Insulet's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Insulet's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Insulet's net worth. This approach calculates the present value of Insulet's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Insulet's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Insulet's net worth. This involves comparing Insulet's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Insulet's net worth relative to its peers.

Enterprise Value

10.29 Billion

To determine if Insulet is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Insulet's net worth research are outlined below:
Insulet generated a negative expected return over the last 90 days
Over 100.0% of the company shares are owned by institutional investors
Latest headline from zacks.com: Chemed Lags Q1 Earnings Estimates, Reaffirms 2024 View

Insulet Quarterly Good Will

51.7 Million

Insulet uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Insulet. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Insulet's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Insulet Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Insulet target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Insulet's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   22  Strong Buy
Most Insulet analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Insulet stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Insulet, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Insulet Target Price Projection

Insulet's current and average target prices are 166.19 and 257.94, respectively. The current price of Insulet is the price at which Insulet is currently trading. On the other hand, Insulet's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Insulet Market Quote on 27th of April 2024

Low Price162.99Odds
High Price168.43Odds

166.19

Target Price

Analyst Consensus On Insulet Target Price

Low Estimate234.73Odds
High Estimate286.31Odds

257.94

Historical Lowest Forecast  234.73 Target Price  257.94 Highest Forecast  286.31
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Insulet and the information provided on this page.

Know Insulet's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Insulet is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Insulet backward and forwards among themselves. Insulet's institutional investor refers to the entity that pools money to purchase Insulet's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Baillie Gifford & Co Limited.2023-12-31
1.2 M
Norges Bank2023-12-31
M
Morgan Stanley - Brokerage Accounts2023-12-31
M
D1 Capital Partners L.p.2023-12-31
M
William Blair Investment Management, Llc2023-12-31
918.7 K
Amvescap Plc.2023-12-31
744.6 K
Westfield Capital Management Company, Lp2023-12-31
705.4 K
Northern Trust Corp2023-12-31
666.6 K
Ameriprise Financial Inc2023-12-31
654.7 K
Capital Research Global Investors2023-12-31
9.5 M
Vanguard Group Inc2023-12-31
M
Note, although Insulet's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Insulet's market capitalization trends

The company currently falls under 'Large-Cap' category with a current market capitalization of 11.71 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Insulet's market, we take the total number of its shares issued and multiply it by Insulet's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

9.8 Billion

Project Insulet's profitablity

Insulet's profitability indicators refer to fundamental financial ratios that showcase Insulet's ability to generate income relative to its revenue or operating costs. If, let's say, Insulet is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Insulet's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Insulet's profitability requires more research than a typical breakdown of Insulet's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.08  0.09 
Return On Capital Employed 0.10  0.11 
Return On Assets 0.08  0.08 
Return On Equity 0.28  0.30 
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26.
When accessing Insulet's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Insulet's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Insulet's profitability and make more informed investment decisions.
The data published in Insulet's official financial statements usually reflect Insulet's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Insulet. For example, before you start analyzing numbers published by Insulet accountants, it's critical to develop an understanding of what Insulet's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Insulet's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Insulet's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Insulet's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Insulet. Please utilize our Beneish M Score to check the likelihood of Insulet's management manipulating its earnings.

Evaluate Insulet's management efficiency

Insulet has return on total asset (ROA) of 0.0609 % which means that it generated a profit of $0.0609 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3413 %, meaning that it created $0.3413 on every $100 dollars invested by stockholders. Insulet's management efficiency ratios could be used to measure how well Insulet manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.09. The current year's Return On Capital Employed is expected to grow to 0.11. At present, Insulet's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 1.1 B, whereas Intangibles To Total Assets are forecasted to decline to 0.06.
Last ReportedProjected for Next Year
Book Value Per Share 10.50  11.03 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 8.35  8.77 
Enterprise Value Over EBITDA 72.42  76.04 
Price Book Value Ratio 20.66  20.25 
Enterprise Value Multiple 72.42  76.04 
Price Fair Value 20.66  20.25 
Enterprise Value9.8 B10.3 B
The analysis of Insulet's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Insulet's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Insulet Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue
7.6514
Revenue
1.7 B
Quarterly Revenue Growth
0.379
Revenue Per Share
24.331
Return On Equity
0.3413
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Insulet insiders, such as employees or executives, is commonly permitted as long as it does not rely on Insulet's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Insulet insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Insulet Corporate Filings

F3
25th of April 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
9th of April 2024
Other Reports
ViewVerify
8K
20th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
29th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
Insulet time-series forecasting models is one of many Insulet's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Insulet's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Insulet Earnings Estimation Breakdown

The calculation of Insulet's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Insulet is estimated to be 0.38 with the future projection ranging from a low of 0.28 to a high of 0.61. Please be aware that this consensus of annual earnings estimates for Insulet is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
1.4
0.28
Lowest
Expected EPS
0.38
0.61
Highest

Insulet Earnings Projection Consensus

Suppose the current estimates of Insulet's value are higher than the current market price of the Insulet stock. In this case, investors may conclude that Insulet is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Insulet's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2024Current EPS (TTM)
1743.73%
1.4
0.38
2.94

Insulet Earnings per Share Projection vs Actual

Actual Earning per Share of Insulet refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Insulet predict the company's earnings will be in the future. The higher the earnings per share of Insulet, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Insulet Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Insulet, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Insulet should always be considered in relation to other companies to make a more educated investment decision.

Insulet Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Insulet's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-03-08
2023-12-310.661.40.74112 
2023-11-02
2023-09-300.40.710.3177 
2023-08-08
2023-06-300.260.380.1246 
2023-05-04
2023-03-310.110.230.12109 
2023-02-23
2022-12-310.210.240.0314 
2022-11-03
2022-09-300.150.350.2133 
2022-08-04
2022-06-300.22-0.5-0.72327 
2022-05-05
2022-03-310.230.40.1773 
2022-02-23
2021-12-310.320.420.131 
2021-11-04
2021-09-300.240.18-0.0625 
2021-08-05
2021-06-300.130.230.176 
null
nullnullnullnull
2021-02-23
2020-12-31-0.04-0.040.0
2020-11-04
2020-09-300.080.170.09112 
2020-08-06
2020-06-300.0110.220.2091900 
2020-05-07
2020-03-31-0.01-0.03-0.02200 
2020-02-25
2019-12-310.110.08-0.0327 
2019-11-05
2019-09-300.030.01-0.0266 
2019-08-05
2019-06-300.020.020.0
2019-05-02
2019-03-310.010.070.06600 
2019-02-25
2018-12-310.070.160.09128 
2018-11-01
2018-09-300.020.030.0150 
2018-08-02
2018-06-30-0.13-0.030.176 
2018-05-03
2018-03-31-0.19-0.110.0842 
2018-02-21
2017-12-31-0.08-0.12-0.0450 
2017-11-02
2017-09-30-0.1-0.040.0660 
2017-08-03
2017-06-30-0.13-0.130.0
2017-05-08
2017-03-31-0.15-0.17-0.0213 
2017-02-27
2016-12-31-0.05-0.16-0.11220 
2016-11-03
2016-09-30-0.09-0.050.0444 
2016-08-03
2016-06-30-0.17-0.080.0952 
2016-04-28
2016-03-31-0.19-0.22-0.0315 
2016-02-25
2015-12-31-0.26-0.28-0.02
2015-11-05
2015-09-30-0.26-0.33-0.0726 
2015-08-12
2015-06-30-0.13-0.27-0.14107 
2015-04-30
2015-03-31-0.1-0.21-0.11110 
2015-02-26
2014-12-31-0.04-0.1-0.06150 
2014-11-05
2014-09-30-0.01-0.12-0.111100 
2014-08-07
2014-06-30-0.08-0.060.0225 
2014-05-07
2014-03-31-0.06-0.11-0.0583 
2014-02-27
2013-12-31-0.09-0.040.0555 
2013-11-07
2013-09-30-0.16-0.21-0.0531 
2013-08-07
2013-06-30-0.19-0.2-0.01
2013-05-06
2013-03-31-0.21-0.20.01
2013-02-27
2012-12-31-0.22-0.210.01
2012-11-08
2012-09-30-0.24-0.26-0.02
2012-08-08
2012-06-30-0.26-0.3-0.0415 
2012-05-09
2012-03-31-0.28-0.31-0.0310 
2012-02-09
2011-12-31-0.26-0.3-0.0415 
2011-11-03
2011-09-30-0.25-0.29-0.0416 
2011-08-02
2011-06-30-0.23-0.42-0.1982 
2011-05-09
2011-03-31-0.22-0.220.0
2011-02-15
2010-12-31-0.26-0.260.0
2010-11-09
2010-09-30-0.3-0.30.0
2010-07-29
2010-06-30-0.35-0.36-0.01
2010-05-06
2010-03-31-0.38-0.370.01
2010-02-09
2009-12-31-0.47-0.420.0510 
2009-10-26
2009-09-30-0.7-0.88-0.1825 
2009-08-04
2009-06-30-0.68-0.73-0.05
2009-05-07
2009-03-31-0.65-0.71-0.06
2009-03-05
2008-12-31-0.63-1.02-0.3961 
2008-11-06
2008-09-30-0.74-0.75-0.01
2008-08-12
2008-06-30-0.7-0.87-0.1724 
2008-05-13
2008-03-31-0.56-0.73-0.1730 
2008-03-17
2007-12-31-0.51-0.59-0.0815 
2007-11-14
2007-09-30-0.5-0.52-0.02
2007-08-14
2007-06-30-0.56-0.99-0.4376 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Insulet without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Insulet Corporate Directors

Insulet corporate directors refer to members of an Insulet board of directors. The board of directors generally takes responsibility for the Insulet's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Insulet's board members must vote for the resolution. The Insulet board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Sally CrawfordLead Independent DirectorProfile
John FallonIndependent DirectorProfile
Daniel LevangieIndependent DirectorProfile
James MullenIndependent DirectorProfile

How to buy Insulet Stock?

The net worth of Insulet is the difference between its total assets and liabilities. Insulet's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Insulet's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Insulet's net worth can be used as a measure of its financial health and stability which can help investors to decide if Insulet is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Insulet stock.

Already Invested in Insulet?

The danger of trading Insulet is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Insulet is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Insulet. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Insulet is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
Note that the Insulet information on this page should be used as a complementary analysis to other Insulet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Insulet Stock analysis

When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.043
Earnings Share
2.94
Revenue Per Share
24.331
Quarterly Revenue Growth
0.379
Return On Assets
0.0609
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.